{"id":234600,"date":"2026-01-01T11:44:39","date_gmt":"2026-01-01T11:44:39","guid":{"rendered":"https:\/\/worldpatientsalliance.org\/staging\/events\/the-wpsd-webinar-on-patient-engagement-in-medication-safety\/"},"modified":"2026-01-01T11:44:39","modified_gmt":"2026-01-01T11:44:39","slug":"the-wpsd-webinar-on-patient-engagement-in-medication-safety","status":"publish","type":"mec-events","link":"https:\/\/worldpatientsalliance.org\/staging\/allevents\/the-wpsd-webinar-on-patient-engagement-in-medication-safety\/","title":{"rendered":"The WPSD webinar on Patient Engagement in Medication Safety"},"content":{"rendered":"<style type=\"text\/css\">body.kc-css-system .kc-css-623577.kc_title,body.kc-css-system .kc-css-623577 .kc_title,body.kc-css-system .kc-css-623577 .kc_title a.kc_title_link{font-size: 20px;}body.kc-css-system .kc-css-965248{background: #61b0ff;}body.kc-css-system .kc-css-800437 .kc_button{color: #ffffff;background-color: #1e73be;font-size: 20px;}body.kc-css-system .kc-css-800437{text-align: center;}<\/style>\n<section class=\"kc-elm kc-css-409793 kc_row\">\n<div class=\"kc-row-container  kc-container\">\n<div class=\"kc-wrap-columns\">\n<div class=\"kc-elm kc-css-982820 kc_col-sm-12 kc_column kc_col-sm-12\">\n<div class=\"kc-col-container\">\n<div class=\"kc-elm kc-css-540120 kc_shortcode kc_single_image\">\n<p>        <img decoding=\"async\" src=\"https:\/\/www.worldpatientsalliance.org\/wp-content\/uploads\/wpsd-Webinar-2022-1.jpg\" class=\"\" alt=\"\" \/>    <\/div>\n<div class=\"kc-elm kc-css-210421 kc_text_block\">\n<h2>Patient Engagement in Medication Safety<\/h2>\n<h2>World Patient Safety Day webinar<\/h2>\n<h2>14 September 2022<\/h2>\n<p>The WPA World Patient Safety Day webinar was held on 14 September, 2022. The topic was \u201cPatient Engagement in Medication Safety,\u201d or what patients can do to help keep themselves safe while using medications. This was in keeping with the 2022 World Patient Safety Day theme \u201cMedication without Harm\u201d and the long-running WHO global patient safety challenge on medication safety. Both these WHO campaigns were undertaken in acknowledgement of the fact that adverse events from medications are one of the greatest sources of patient harm in healthcare.<\/p>\n<p>To recognize World Patient Safety Day, WPA gathered four of the world\u2019s leading experts on medication safety. The event was opened by WPA president Andrew Spiegel, who showed the WPA video on actions patients can take to help ensure medication safety. Helen Haskell, WPA Patient Safety Committee member and chair of the Patients and Public Working Group of the global challenge, then introduced the speakers. The first speaker was Alpana Mair, Head of Prescribing and Therapeutics for Scottish Government and a global expert on the simultaneous prescription of multiple medications, or polypharmacy. Dr. Mair gave an enlightening talk about polypharmacy in older adults, who often take more medications than younger people but are more susceptible to side effects and interactions. She also introduced the audience to the many useful online tools that are available through her iSimpathy project in the EU. Dr. Michael Cohen, head of the US Institute for Safe Medication Practices, gave an informative talk with many helpful tips to enable patients to watch for and prevent medication error. Professor Phillip Routledge of Cardiff University in Wales spoke about the special concerns surrounding high-risk situations and medications, using the analogy of the wreck of the Titanic to show how small mistakes can build on each other to lead to catastrophe. The webinar closed with a look at community outreach on medication safety by Dr. Helen Ndagije, Director of Product Safety at the National Drug Authority of Uganda. Dr. Ndagije discussed her pathbreaking program to empower rural patients in Uganda to recognize and report medication side effects, a program that can be a model for many countries.<\/p>\n<p>WPA is honored to have these four experts provide our community with so much practical information on so many important aspects of medication safety.<\/p>\n<\/div>\n<div class=\"kc-elm kc-css-623577 kc-title-wrap \">\n<h1 class=\"kc_title\">Please click here for presentations of the webinar.<\/h1>\n<\/div>\n<div class=\"kc-elm kc-css-821921 kc_shortcode kc_video_play kc_video_wrapper\" data-video=\"https:\/\/youtu.be\/86yN1RLawnM\" data-width=\"600\" data-height=\"338.98305084746\" data-fullwidth=\"\" data-autoplay=\"\" data-loop=\"yes\" data-control=\"yes\" data-related=\"\" data-showinfo=\"\" data-kc-video-mute=\"\">\n\t\t\t<\/div>\n<div class=\"kc-elm kc-css-153318\" style=\"height: 20px; clear: both; width:100%;\"><\/div>\n<div class=\"kc-elm kc-css-683157 kc_text_block\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: center; line-height: normal; vertical-align: baseline;\" align=\"center\"><b style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 18.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">Programme<\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: center; line-height: normal; vertical-align: baseline;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<table class=\"MsoTableGrid\" style=\"width: 530.95pt; margin-left: -27.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;\" border=\"1\" width=\"1062\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr style=\"mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 28.6pt;\">\n<td style=\"width: 530.95pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 28.6pt;\" colspan=\"3\" valign=\"top\" width=\"1062\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: center; line-height: normal; vertical-align: baseline;\" align=\"center\"><b style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 16.0pt;\">14th September\u00a02022 at 10:00 AM EST <\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: center; line-height: normal; vertical-align: baseline;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black;\">\u00a0<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: center; line-height: normal; vertical-align: baseline;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"mso-yfti-irow: 1; height: 22.7pt;\">\n<td style=\"width: 31.5pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 22.7pt;\" valign=\"top\" width=\"63\">\n<p class=\"MsoNormal\" style=\"line-height: normal; vertical-align: baseline; margin: 0in 0in .0001pt .25in;\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 319.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 22.7pt;\" valign=\"top\" width=\"639\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; vertical-align: baseline;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Welcome from WPA<\/span><\/p>\n<\/td>\n<td style=\"width: 179.95pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 22.7pt;\" valign=\"top\" width=\"360\">\n<p class=\"TableParagraph\" style=\"text-align: justify; margin: 5.05pt 0in .0001pt 0in;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Andrew Spiegel<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"mso-yfti-irow: 2; height: 21.45pt;\">\n<td style=\"width: 31.5pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 21.45pt;\" valign=\"top\" width=\"63\">\n<p class=\"MsoNormal\" style=\"text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in .0001pt .25in;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 319.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 21.45pt;\" valign=\"top\" width=\"639\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; vertical-align: baseline;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Introduction to World Patients Safety Day<\/span><\/p>\n<\/td>\n<td style=\"width: 179.95pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 21.45pt;\" valign=\"top\" width=\"360\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Helen Haskell<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"mso-yfti-irow: 3; height: 21.45pt;\">\n<td style=\"width: 31.5pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 21.45pt;\" valign=\"top\" width=\"63\">\n<p class=\"MsoNormal\" style=\"text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in .0001pt .25in;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 319.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 21.45pt;\" valign=\"top\" width=\"639\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; vertical-align: baseline;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Medication safety in polypharmacy<\/span><\/p>\n<\/td>\n<td style=\"width: 179.95pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 21.45pt;\" valign=\"top\" width=\"360\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Alpana Mair<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"mso-yfti-irow: 4; height: 18.85pt;\">\n<td style=\"width: 31.5pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 18.85pt;\" valign=\"top\" width=\"63\">\n<p class=\"MsoNormal\" style=\"text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in .0001pt .25in;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 319.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 18.85pt;\" valign=\"top\" width=\"639\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; vertical-align: baseline;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Taking medications safely<\/span><span style=\"font-size: 11.5pt; font-family: &#039;Segoe UI&#039;,&#039;sans-serif&#039;; color: #201f1e; background: white;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 179.95pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 18.85pt;\" valign=\"top\" width=\"360\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; text-align: justify; line-height: normal;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Michael R. Cohen<b><\/b><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"mso-yfti-irow: 5; height: 25.05pt;\">\n<td style=\"width: 31.5pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"63\">\n<p class=\"MsoNormal\" style=\"text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in .0001pt .25in;\" align=\"center\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 319.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"639\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; tab-stops: 53.4pt center 118.35pt; vertical-align: baseline;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">High risk situations and medications<\/span><\/p>\n<\/td>\n<td style=\"width: 179.95pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"360\">\n<p class=\"TableParagraph\" style=\"margin: 3.05pt 0in .0001pt 0in;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Prof. Philip Routledge<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"mso-yfti-irow: 6; height: 24.15pt;\">\n<td style=\"width: 31.5pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 24.15pt;\" valign=\"top\" width=\"63\">\n<p class=\"MsoNormal\" style=\"text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in .0001pt .25in;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 319.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 24.15pt;\" valign=\"top\" width=\"639\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; vertical-align: baseline;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Community outreach on medication safety<\/span><\/p>\n<\/td>\n<td style=\"width: 179.95pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 24.15pt;\" valign=\"top\" width=\"360\">\n<p class=\"TableParagraph\" style=\"margin: 3.05pt 0in .0001pt 0in;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Dr. Helen Ndagije<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"mso-yfti-irow: 7; height: 25.05pt;\">\n<td style=\"width: 31.5pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"63\">\n<p class=\"MsoNormal\" style=\"text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in .0001pt .25in;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 319.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"639\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; vertical-align: baseline;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Q&#038;A and speaker discussion<\/span><\/p>\n<\/td>\n<td style=\"width: 179.95pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"360\">\n<p class=\"TableParagraph\" style=\"margin: 3.05pt 0in .0001pt 0in;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Moderator: Helen Haskell<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"mso-yfti-irow: 8; mso-yfti-lastrow: yes; height: 25.05pt;\">\n<td style=\"width: 31.5pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"63\">\n<p class=\"MsoNormal\" style=\"text-align: center; line-height: normal; vertical-align: baseline; margin: 0in 0in .0001pt .25in;\" align=\"center\"><span style=\"font-size: 12.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;; mso-fareast-font-family: &#039;Times New Roman&#039;; color: black; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;\">\u00a0<\/span><\/p>\n<\/td>\n<td style=\"width: 319.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"639\">\n<p class=\"MsoNormal\" style=\"margin-bottom: .0001pt; line-height: normal; vertical-align: baseline;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Closing Remarks<\/span><\/p>\n<\/td>\n<td style=\"width: 179.95pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 25.05pt;\" valign=\"top\" width=\"360\">\n<p class=\"TableParagraph\" style=\"margin: 3.05pt 0in .0001pt 0in;\"><span style=\"font-size: 12.0pt; mso-bidi-font-size: 11.0pt; font-family: &#039;Arial&#039;,&#039;sans-serif&#039;;\">Helen Haskell<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"kc-elm kc-css-254845\" style=\"height: 10px; clear: both; width:100%;\"><\/div>\n<div class=\"kc-elm kc-css-739728 kc-title-wrap \">\n<h1 class=\"kc_title\">Speakers<\/h1>\n<\/div>\n<div data-open-on-mouseover=\"\" data-tab-active=\"1\" data-effect-option=\"\" class=\"kc-elm kc-css-859445 kc_tabs group\">\n<div class=\"kc_wrapper ui-tabs kc_clearfix\">\n<ul class=\"kc_tabs_nav ui-tabs-nav kc_clearfix\">\n<li><a href=\"#\" data-prevent=\"scroll\">Andrew Spiegel<\/a><\/li>\n<li><a href=\"#\" data-prevent=\"scroll\">Helen Haskell<\/a><\/li>\n<li><a href=\"#\" data-prevent=\"scroll\">Alpana Mair<\/a><\/li>\n<li><a href=\"#\" data-prevent=\"scroll\">Michael R. Cohen<\/a><\/li>\n<li><a href=\"#\" data-prevent=\"scroll\">Prof Philip Routledge<\/a><\/li>\n<li><a href=\"#\" data-prevent=\"scroll\">Helen Byomire Ndagije<\/a><\/li>\n<\/ul>\n<div id=\"andrew-spiegel\" class=\"kc-elm kc-css-965248 kc_tab ui-tabs-panel kc_ui-tabs-hide kc_clearfix \">\n<div class=\"kc_tab_content\">\n<div class=\"kc-elm kc-css-513626 kc-feature-boxes kc-fb-layout-2\">\n<figure class=\"content-image\"><img decoding=\"async\" src=\"https:\/\/www.worldpatientsalliance.org\/wp-content\/uploads\/andrew.png\" alt=\"\"><\/figure>\n<div class=\"content-title\">Andrew Spiegel<\/div>\n<div class=\"content-desc\">Andrew Spiegel has nearly two decades of experience in the patient advocacy arena. Spiegel co-founded the Colorectal Cancer Alliance, now the leading US based national patient advocacy organization dedicated to colon cancer. Mr. Spiegel, an attorney, besides being a co-founder of the organization and longtime board member of the Alliance became CEO in January of 2008 and he ran the CCA for nearly 5 years, before undertaking his next venture, the Global Colon Cancer Association (GCCA). Currently, Spiegel is co-founder and executive director of the GCCA, an international patient advocacy organization. This organization is an international community of nearly 50 colon cancer patient advocacy organizations and stakeholders dedicated to end the worldwide suffering of the 3rd leading cause of cancer deaths. In addition to his work in the colon cancer community, Spiegelis an active advocate for health care policies both in the US and now worldwide. He is a co-founder and currently serves on the steering committee of the Alliance for Safe Biologic Medicines (ASBM). He is on the Board of Directors, and in December 2014 was elected to Chair, of the Digestive Disease National Coalition (DDNC),a founding member of the Coalition to Increase Clinical Trial Participation and in May of 2016 he began a three year term as a member of the Board of Directors of the International Alliance of Patient Organizations (IAPO) where he chaired the fundraising committee. Spiegel has won multiple awards for his work in patient advocacy. Spiegel is a 1986 graduate of Temple University in Philadelphia where he earned a Bachelor\u2019s degree in Political Science with minors in English and Philosophy. He is a 1989 graduate of the Widener University School of Law. After working for a Philadelphia litigation firm, Spiegel opened his own law firm in 1995.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"helen-haskell\" class=\"kc-elm kc-css-614959 kc_tab ui-tabs-panel kc_ui-tabs-hide kc_clearfix \">\n<div class=\"kc_tab_content\">\n<div class=\"kc-elm kc-css-224917 kc-feature-boxes kc-fb-layout-2\">\n<figure class=\"content-image\"><img decoding=\"async\" src=\"https:\/\/www.worldpatientsalliance.org\/wp-content\/uploads\/Helen-Haskell.png\" alt=\"\"><\/figure>\n<div class=\"content-title\">Helen Haskell<\/div>\n<div class=\"content-desc\">Helen Haskell is president of the nonprofit patient organizations Mothers Against Medical Error and Consumers Advancing Patient Safety. She is an Institute for Healthcare Improvement senior fellow, a board member of the Patient Safety Action Network, and previous co-chair of the WHO Patients for Patient Safety Advisory Group. Helen\u2019s goal since the medical error death of her young son Lewis has been to enhance the patient contribution to safety and quality in healthcare. She has written and co-authored numerous articles, book chapters, and educational materials on patient engagement in safety and quality, including a co-edited textbook of case studies from the patient perspective. Her son Lewis\u2019s story has been featured in educational programs and videos including Transparent Health\u2019s full-length Lewis Blackman Story. Helen holds a bachelor&#8217;s degree in Classical Studies from Duke University and a master\u2019s degree in Anthropology from Rice University in the United States.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"alpana-mair\" class=\"kc-elm kc-css-383509 kc_tab ui-tabs-panel kc_ui-tabs-hide kc_clearfix \">\n<div class=\"kc_tab_content\">\n<div class=\"kc-elm kc-css-502087 kc-feature-boxes kc-fb-layout-2\">\n<figure class=\"content-image\"><img decoding=\"async\" src=\"https:\/\/www.worldpatientsalliance.org\/wp-content\/uploads\/Alpana-Mair.png\" alt=\"\"><\/figure>\n<div class=\"content-title\">Alpana Mair<\/div>\n<div class=\"content-desc\">As Head of Prescribing and Therapeutics for the Scottish Government, and previous Deputy Chief Pharmaceutical Officer for Scotland, Alpana is responsible for coordinating delivery of the government\u2019s work programme and advising ministers on quality, safety and effectiveness of medicines. Recently she has been working as part of the government\u2019s team on the COVID response.  She is responsible for development of National Polypharmacy clinical guidance, patient app and shared decision-making tools. Alpana has recently been awarded EU funding for implementation of a polypharmacy and adherence programme across three countries, for people with multimorbidities &#8211; iSIMPATHY (Simulating Innovation in the Management of Polypharmacy and Adherence Through The Years) &#8211; &#038; led successful delivery of the European funded project SIMPATHY (Simulating Innovation in the Management of Polypharmacy and Adherence in the elderly). She leads work for WHO on Polypharmacy and is an expert adviser and consultant for WHO on patient safety. For International Foundation of Integrated Care (IFIC), she coordinates the Special Interest Group on Appropriate polypharmacy &#038; Adherence and is EU coordinator for work on Active and Healthy Aging on polypharmacy and adherence to treatment. As Quality and Safety fellow, she runs clinics and has received Health Improvement funding to develop a street outreach to improve homeless people\u2019s management of multiple morbidities and medicines with third sector partners.<br \/>\nShe holds a leadership Masters from Harvard\/Napier and is Associate Professor at Napier University and honorary senior lecturer at Robert Gordon and Strathclyde University.\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"michael-r-cohen\" class=\"kc-elm kc-css-162574 kc_tab ui-tabs-panel kc_ui-tabs-hide kc_clearfix \">\n<div class=\"kc_tab_content\">\n<div class=\"kc-elm kc-css-349843 kc-feature-boxes kc-fb-layout-2\">\n<figure class=\"content-image\"><img decoding=\"async\" src=\"https:\/\/www.worldpatientsalliance.org\/wp-content\/uploads\/Michael-R-Cohen.png\" alt=\"\"><\/figure>\n<div class=\"content-title\">Michael R. Cohen<\/div>\n<div class=\"content-desc\">Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP is president emeritus of The Institute for Safe Medication Practices (ISMP), a non-profit healthcare organization that specializes in understanding the causes of medication errors, providing error-reduction strategies to the healthcare community, policy makers, and the public. Cohen serves as co-editor of the ISMP Medication Safety Alert! publications that reach over one million health professionals in the US as well as regulatory authorities and others in over 30 foreign countries. He is also co-editor of the ISMP consumer website, www.consumermedsafety.org. Cohen is the Chairperson of the International Medication Safety Network (www.intmedsafe.net). He has served terms on the US FDA Drug Safety and Risk Management Advisory Committee (DSaRM) and the Nonprescription Drugs Advisory Committee (NDAC). He is currently a consultant to FDA and Vice Chair of the United States Pharmacopeia (USP) Expert Committee on Nomenclature and Labeling. Among recognitions he has received, he is a recipient of the John M. Eisenberg Patient Safety and Quality Award from the National Quality Forum and the Joint Commission, the Harvey A. K. Whitney Award from the American Society of Health-System Pharmacists and he has also been recognized as a MacArthur Fellow by the John D. and Catherine T. MacArthur Foundation.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"prof-philip-routledge\" class=\"kc-elm kc-css-663118 kc_tab ui-tabs-panel kc_ui-tabs-hide kc_clearfix \">\n<div class=\"kc_tab_content\">\n<div class=\"kc-elm kc-css-6568 kc-feature-boxes kc-fb-layout-2\">\n<figure class=\"content-image\"><img decoding=\"async\" src=\"https:\/\/www.worldpatientsalliance.org\/wp-content\/uploads\/Professor-Philip-Routledge.png\" alt=\"\"><\/figure>\n<div class=\"content-title\">Professor Philip Routledge<\/div>\n<div class=\"content-desc\">Philip is a retired consultant physician (General internal Medicine), clinical pharmacologist and toxicologist who worked in Cardiff University, Wales, UK from 1981 until 2016. He was founding Clinical Director of the All-Wales Therapeutics and Toxicology Centre (AWTTC) based at University Hospital Llandough (UHL) in Penarth, Wales. He also co-founded the Wales pharmacovigilance centre, the Yellow Card Centre Wales in 1984, and established the Cardiff Poisons Treatment Unit at UHL in 1986. He was Medical Director of the Cardiff Poisons Information Service (part of the UK National Poisons Information Service) from 1984 until 2005 and Professor of Clinical Pharmacology in Cardiff University from 1989 until 2016.<br \/>\nHis present research interests are in promoting the safe and effective use of medicines. He was the main author on the 2019 WHO technical report \u201cHigh Risk Situations in Medication Safety\u201d. He is Emeritus Professor of Clinical Pharmacology in Cardiff University and a President Emeritus of the British Pharmacological Society. He was appointed OBE in 2008 and CBE in 2018, both for services to medicine.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"helen-byomire-ndagije\" class=\"kc-elm kc-css-175168 kc_tab ui-tabs-panel kc_ui-tabs-hide kc_clearfix \">\n<div class=\"kc_tab_content\">\n<div class=\"kc-elm kc-css-443658 kc-feature-boxes kc-fb-layout-2\">\n<figure class=\"content-image\"><img decoding=\"async\" src=\"https:\/\/www.worldpatientsalliance.org\/wp-content\/uploads\/Helen-Byomire-Ndagije.png\" alt=\"\"><\/figure>\n<div class=\"content-title\">Helen Byomire Ndagije<\/div>\n<div class=\"content-desc\">Helen Byomire Ndagije, a pharmacist and clinical epidemiologist is the Director of Product Safety at the National Drug Authority in Uganda. She is the President of the African Society of Pharmacovigilance, holds a masters in business administration and a doctorate in public health. She is known for having introduced a decentralised system of pharmacovigilance in Uganda. She has also been the Vice Chairperson of the African Vaccine Regulator\u2019s Forum (AVAREF), a network that has seen the regulatory system for clinical trials of medicines and vaccines uplifted in the last 10 years. The WHO supported AVAREF initiative of the 24 member countries meets annually and the last meeting was hosted by Uganda.<\/p>\n<p>In August 2014, Helen also participated as a member of the expert panel to advise WHO of the ethical considerations for the use of unregistered interventions for the Ebola Viral disease. She is also a member of the Tuberculosis Technical Expert group and various such other groups. Currently, Helen is also part of the East African Community Pharmacovigilance Expert working group.<\/p>\n<p>Previously, Helen was a clinical trial manager for a project by the Medical Research Council in Uganda; Development of Anti-retroviral Therapy, after her excellent performance and completion of a phase II microbicide project in Uganda.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"kc-elm kc-css-800437\">\n\t<a class=\"kc_button\" href=\"https:\/\/www.worldpatientsalliance.org\/medication-safety-links-and-resources\/\" target=\"_self\" title=\"Medication Safety Links and Resources\" onclick=\"\"><br \/>\n\t\tMedication Safety Links and Resources\t<\/a>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<section class=\"kc-elm kc-css-269439 kc_row\">\n<div class=\"kc-row-container  kc-container\">\n<div class=\"kc-wrap-columns\">\n<div class=\"kc-elm kc-css-480028 kc_col-sm-12 kc_column kc_col-sm-12\">\n<div class=\"kc-col-container\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Patient Engagement in Medication Safety World Patient Safety Day webinar 14 September 2022 The WPA World Patient Safety Day webinar was held on 14 September, 2022. The topic was \u201cPatient [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":234601,"comment_status":"closed","ping_status":"closed","template":"","tags":[],"mec_category":[18,20],"class_list":["post-234600","mec-events","type-mec-events","status-publish","has-post-thumbnail","hentry","mec_category-activities","mec_category-webinars"],"_links":{"self":[{"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/mec-events\/234600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/mec-events"}],"about":[{"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/types\/mec-events"}],"author":[{"embeddable":true,"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/comments?post=234600"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/media\/234601"}],"wp:attachment":[{"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/media?parent=234600"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/tags?post=234600"},{"taxonomy":"mec_category","embeddable":true,"href":"https:\/\/worldpatientsalliance.org\/staging\/wp-json\/wp\/v2\/mec_category?post=234600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}